Primary cytomegalovirus infection in liver transplant recipients: Comparison of infections transmitted via donor organs and via transfusions

Clinical Infectious Diseases

Volumn 23, Issue 2, 1996, Pages 292-297

  Falagas, Matthew E ^b   Snydman, David R ^a   Ruthazer, Robin ^b   Griffith, John ^b   Werner, Barbara G ^b  

^a TUFTS MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD TRANSFUSION; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; FEMALE; HUMAN; INFANT; LIVER TRANSPLANTATION; MALE; MYCOSIS; ORGAN DONOR; PRIORITY JOURNAL; RECIPIENT; VIRUS HEPATITIS; VIRUS TRANSMISSION;

EID: 0029790264     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinids/23.2.292     Document Type: Article

References (22)

1. Wiesner RH, Marin E, Porayko MK, Steers JL, Krom RAF, Paya CV. Advances in the diagnosis, treatment, and prevention of cytomegalovirus infections after liver transplantation. Gastroenterol Clin North Am 1993;22:351-66.
2. Stratta RJ, Shaeffer MS, Markin RS, et al. Cytomegalovirus infection and disease after liver transplantation: an overview. Dig Dis Sci 1992;37:673-88.
3. Ho M. Cytomegalovirus: biology and infection. 2nd ed. New York: Plenum, 1991:252-6.
4. Singh N, Dummer JS, Kusne S, et al. Infections with cytomegalovirus and other herpesviruses in 121 liver transplant recipients: transmission by the donated organ and the effect of OKT3 antibodies. J Infect Dis 1988;158:124-31.
5. Snydman DR, Werner BG, Dougherty NN, et al. Cytomegalovirus immune globulin prophylaxis in liver transplantation: a randomized, double-blind, placebo-controlled trial. Ann Intern Med 1993;119:984-91.
6. Arbo MDJ, Snydman DR. Influence of blood culture results on antibiotic choice in the treatment of bacteremia. Arch Intern Med 1994;154:2641-5.
7. SAS/STAT user's guide, version 6. 4th ed. Cary, North Carolina: SAS Institute, 1990.
8. Mañez R, Kusne S, Martin M, et al. The impact of blood transfusion on the occurrence of pneumonitis in primary cytomegalovirus infection after liver transplantation. Transfusion 1993;33:594-7.
9. Meyers JD, Leszczynski J, Zaia JA, et al. Prevention of cytomegalovirus infection by cytomegalovirus immune globulin after marrow transplantation. Ann Intern Med 1983;98:442-6.
10. Snydman DR, Werner BG, Dougherty NN, et al. A further analysis of the use of cytomegalovirus immune globulin in orthotopic liver transplant patients at risk for primary infection. Transpl Proc 1994;26(suppl 1):23-7.
11. Portela D, Patel R, Larson-Keller JJ, et al. OKT3 treatment for allograft rejection is a risk factor for cytomegalovirus disease in liver transplantation. J Infect Dis 1995;171:1014-8.
12. Rubin RH, Tolkoff-Rubin NE, Oliver D, et al. Multicenter seroepidemiologic study of the impact of cytomegalovirus infection on renal transplantation. Transplantation 1985;40:243-9.
13. Fox JC, Kidd IM, Griffiths PD, Sweny P, Emery VC. Longitudinal analysis of cytomegalovirus load in renal transplant recipients using a quantitative polymerase chain reaction: correlation with disease. J Gen Virol 1995;76:309-19.
14. Reddehase MJ, Balthesen M, Rapp M, Jonjić S, Pavić I, Koszinowski UH. The conditions of primary infection define the load of latent viral genome in organs and the risk of recurrent cytomegalovirus disease. J Exp Med 1994;179:185-93.
15. Gor D, Vyas N, Man S, Prentice HG, Griffiths PD, Emery VC. Human cytomegalovirus pathogenesis and antiviral therapy in bone marrow transplant recipients: oscillations in viral burden and relationship with disease [abstract no H127]. In: Program and abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy (San Francisco). Washington, DC: American Society for Microbiology, 1995.
16. Mañez R, White LT, Linden P, et al. The influence of HLA matching on cytomegalovirus hepatitis and chronic rejection after liver transplantation. Transplantation 1993;55:1067-71.
17. van Prooijen HC, Visser JJ, van Oostendorp WR, de Gast GC, Verdonck LF. Prevention of primary transfusion-associated cytomegalovirus infection in bone marrow transplant recipients by the removal of white cells from blood components with high-affinity filters. Br J Haematol 1994;87:144-7.
18. Sayers MH, Anderson KC, Goodnough LT, et al. Reducing the risk for transfusion-transmitted cytomegalovirus infection. Ann Intern Med 1992;116:55-62.
19. Winston DJ, Wirin D, Shaked A, Busuttil RW. Randomised comparison of ganciclovir and high-dose acyclovir for long-term cytomegalovirus prophylaxis in liver-transplant recipients. Lancet 1995;346:69-74.
20. Patel R, Snydman DR, Rubin RH, Ho M, Pescovitz M, Martin M. Cytomegalovirus prophylaxis in solid organ transplant recipients. Transplantation 1996;61 (in press).
21. Snydman DR, Falagas ME. Prevention of cytomegalovirus disease in transplant recipients [letter]. Lancet 1996;347:268-9.
22. Snydman DR. Antiviral antibodies in transplantation. Transplant Proc 1995;27(suppl 1):10-2.